CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Alnylam bulls and bears fight it out after business-shaking guidance cut

EarningsNegative
AI Analysis

Summary

Alnylam cut its revenue guidance, causing investor concern, though analysts remain broadly bullish on the company's commercial prospects.

Financial Highlights

Guidance

reduced

Importance:5/10
Sentiment:
-0.30
guidance cutrevenue guidancemarket reactionanalyst sentiment
Related Companies

Read the original article

Published by BioSpace on October 14, 2026 4:53 AM

Read Original